Search for: "Levi v Levi" Results 3281 - 3300 of 3,414
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Mar 2011, 9:21 pm by Kenneth Anderson
II Peter Beinart (whose book I reviewed here) correctly notes that the foreign policy makers - Samantha Power in the Obama administration, for example, or Bernard Henri-Levy in France - cut their teeth on Bosnia. [read post]
29 Feb 2024, 7:15 pm by Barbara Moreno
Levy, ed., Handbook of Legal Tech (2023). [read post]
16 Oct 2017, 11:19 am by Ron Coleman
” The Board routinely takes judicial notice of dictionary definitions when supplied with a copy of the definition, Univ. of Notre Dame du Lac v. [read post]
15 May 2009, 8:27 am
The Trustee seems to be relying heavily on the 85 year old decision in Cunningham v. [read post]
31 Jul 2018, 10:40 am by Kevin Kaufman
This illustrates one of the shortcomings of capital stock taxes: they are levied without regard to ability to pay, imposing burdens even when a business is losing money. [read post]
3 Nov 2013, 8:05 pm by Ken White
Gawker and Sheldon v. [read post]
18 Mar 2024, 4:32 am by Peter Mahler
The Appellate Division last week in Behler v Tao (read here) affirmed the order below in a 3-2 decision featuring a majority opinion authored by Presiding Justice Sallie Manzanet-Daniels, applying what she labels “explicitly contractarian” Delaware LLC law “sometimes leading to harsh results,” and a dissenting opinion authored by Justice Ellen Gesmer exalting “basic principles of contract law and fundamental fairness. [read post]
26 Dec 2011, 9:28 pm by Lyle Denniston
   But, since the very first enumerated power in Article I, Section 8, is to levy taxes, the implication is that the lawmakers can spend what the Treasury gathers in tax revenue. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
9 Jun 2021, 9:34 am by Howard Knopf
 Maître Audet, the Board’s General Counsel, noted some possible questions arising from the pending SCC York University v. [read post]